On Monday shares of Celsion Corp. (NASDAQ:CLSN) closed at $2.65. Celsion Corporation (NASDAQ:CLSN) reported the publication of an abstract in the prestigious Journal of Controlled Release summarizing findings from a preclinical study confirming effective delivery of RNA to lung cells.
Transition Therapeutics Inc. (NASDAQ:TTHI) in last trading activity increased 3.62% to close at $6.93. Company weekly performance is 3.62% while its quarterly performance stands at 3.01%. Transition Therapeutics Inc. (NASDAQ:TTHI) is -18.44% away from its 52 week high. Transition Therapeutics Inc. (NASDAQ:TTHI) announced its financial results for the three and nine month periods ended March 31, 2015. For the three month period ended March 31, 2015, the Company recorded a net loss of $4,748,096 ($0.13 loss per common share) compared to a net loss of $5,067,292 ($0.17 loss per common share) for the three month period ended March 31, 2014.
On last trading day NMI Holdings, Inc. (NASDAQ:NMIH) moved down -0.73% to close at $8.14. Its volatility for the week is 2.38% while volatility for the month is 2.86%. NMI Holdings, Inc. (NASDAQ:NMIH) monthly performance is 7.67%. BTIG Research set a $10.00 target price on NMI Holdings (NASDAQ:NMIH) in a report. The firm currently has a buy rating on the stock.
Summer Infant, Inc. (NASDAQ:SUMR) has 2.70% insider ownership while its institutional ownership stands at 54.50%. In last trading activity company’s stock closed at $2.62. Summer Infant, Inc. (NASDAQ:SUMR) on 6 May, announced that Robert Stebenne, the Company’s President and Chief Operating Officer, has been named the Company’s new Chief Executive Officer, succeeding Carol Bramson, who has resigned.
On last trading day Cempra, Inc. (NASDAQ:CEMP) increased 2.20% to close at $34.89. Its volatility for the week is 3.85% while volatility for the month is 5.51%. CEMP’s EPS growth for past 5 years was -11.30%. Cempra, Inc. (NASDAQ:CEMP) monthly performance is -5.93%. Cempra, Inc. (NASDAQ:CEMP) on May 12, 2015, reported that it will be participating in the American Thoracic Society (ATS) International Conference 2015, May 15-20, and the Community Acquired Pneumonia Organization (CAPO) Symposium on May 20-21. Both meetings are being held in Denver.